The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study.
Saved in:
| Title: | The new topical ascomycin derivative SDZ ASM 981 does not induce skin atrophy when applied to normal skin for 4 weeks: a randomized, double-blind controlled study. |
|---|---|
| Authors: | Queille-Roussel, C., Paul, C.1, Duteil, L., Lefebvre, M-C.1, Rapatz, G.1, Zagula, M.2, Ortonne, J-P. |
| Source: | British Journal of Dermatology. Mar2001, Vol. 144 Issue 3, p507-513. 7p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070963 |
|---|---|
| DOI: | 10.1046/j.1365-2133.2001.04076.x |
